ResMed reported $194.89M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Ansell ANN:AU USD 200.5M 11.2M
Cochlear COH:AU AUD 355.8M 53.9M
CSL CSL:AU USD 900.7M 152.7M
Estia Health EHE:AU AUD 279.8M 22.01M
Fisher & Paykel Healthcare FPH:AU NZD 202.3M 1.2M
Healius Ltd HLS:AU AUD 541.5M 43.6M
Integral Diagnostics Ltd IDX:AU AUD 111.52M 3.96M
Mayne Pharma MYX:AU AUD 90.44M 18.02M
Nanosonics Ltd NAN:AU AUD 36.21M 4.26M
Opthea Ltd OPT:AU USD 18.44M 10.79M
Polynovo Ltd PNV:AU AUD 19.49M 7.16M
Ramsay Health Care RHC:AU AUD 4.35B 398.7M
Regis Healthcare REG:AU AUD 359.23M 39.82M
ResMed RMD:AU USD 194.89M 12.49M
Sigma Healthcare Ltd SIG:AU AUD 148.5M 10.53M
Sonic Healthcare SHL:AU AUD 2.21B 139.2M
Telix Pharmaceuticals Ltd TLX:AU AUD 49.39M 19.56M